RCO Stock Analysis: Remy Cointreau | PA
Beverages - Wineries & Distilleries | PA, France | Market Cap: 2.605m EUR | 12M Return: 18.3% | FR0000130395 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 3.58M
Warnings
No concerns identified
Tailwinds
Seasonality 11.8 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Rémy Cointreau SA is a France-based producer and distributor of premium liqueurs and spirits, operating through three segments: Rémy Martin (cognac), Liqueurs & Spirits, and Partner Brands. Its portfolio spans cognacs, liqueurs, single malt whiskies, gins, rums, brandies, wines, and champagnes, marketed under flagship names such as Rémy Martin, LOUIS XIII, Cointreau, Metaxa, Bruichladdich, The Botanist, and Mount Gay. The company distributes its products across Europe, the Middle East, Africa, the Americas, Asia, Australia, and New Zealand, and is headquartered in Cognac, France, with roots dating back to 1724.
The company sits in the GICS Distillers & Vintners sub-industry, a consumer staples segment whose performance is closely tied to global demand for premium and luxury spirits, particularly in Asian and U.S. markets. Its business model relies on a brand-led strategy, prioritizing high-margin aged and prestige spirits (notably cognac) over volume-driven categories, with revenue heavily dependent on export markets and on-trade (bars, hotels, restaurants) channels.
- China cognac destocking ends, Rémy Martin shipments rebound
- US tariffs on French spirits squeeze export margins
- Premium liqueur and whisky mix expansion lifts operating margin
| Net Income: 78.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 1.00 > 1.0 |
| NWC/Revenue: 177.6% < 20% (prev 154.3%; Δ 23.34% < -1%) |
| CFO/TA 0.03 > 3% & CFO 90.9m > Net Income 78.7m |
| Net Debt (716.3m) to EBITDA (211.5m): 3.39 < 3 |
| Current Ratio: 3.16 > 1.5 & < 3 |
| Outstanding Shares: last quarter (52.7m) vs 12m ago 2.72% < -2% |
| Gross Margin: 65.84% > 18% (prev 68.14%; Δ -2.30% > 0.5%) |
| Asset Turnover: 27.19% > 50% (prev 28.75%; Δ -1.57% > 0%) |
| Interest Coverage Ratio: 4.86 > 6 (EBIT TTM 165.4m / Interest Expense TTM 34.0m) |
| A: 0.48 (Total Current Assets 2.43b - Total Current Liabilities 770.8m) / Total Assets 3.46b |
| B: 0.28 (Retained Earnings 958.2m / Total Assets 3.46b) |
| C: 0.05 (EBIT TTM 165.4m / Avg Total Assets 3.44b) |
| D: 1.26 (Book Value of Equity 1.93b / Total Liabilities 1.53b) |
| Altman-Z'' = 5.71 = AAA |
| DSRI: 1.07 (Receivables 107.9m/106.6m, Revenue 935.3m/984.6m) |
| GMI: 1.03 (GM 68.14% / 65.84%) |
| AQI: 1.00 (AQ_t 0.16 / AQ_t-1 0.16) |
| SGI: 0.95 (Revenue 935.3m / 984.6m) |
| TATA: -0.00 (NI 78.7m - CFO 90.9m) / TA 3.46b) |
| Beneish M = -2.98 (Cap -4..+1) = A |
As of October 31, 2026, the stock is trading at EUR 50.65 with a total of 111,498 shares traded. Over the past week, the price has changed by -2.88%, over one month by +18.07%, over three months by +4.43% and over the past year by +18.28%.
Current recommended Stop Loss: 48.50 (which is 4.2% or 1.2 ATR below the current price).
Remy Cointreau has no consensus analysts rating.
P/E Trailing = 33.7671
P/E Forward = 22.6244
P/S = 2.7855
P/B = 1.3545
P/EG = 1.262
Revenue TTM = 935.3m EUR
EBIT TTM = 165.4m EUR
EBITDA TTM = 211.5m EUR
Long Term Debt = 665.7m EUR (from longTermDebt, last quarter)
Short Term Debt = 83.8m EUR (from shortTermDebt, last quarter)
Debt = 794.3m EUR (from shortLongTermDebtTotal, last quarter) + Leases 26.0m
Net Debt = 716.3m EUR (calculated: Debt 794.3m - CCE 78.0m)
Enterprise Value = 3.32b EUR (2.61b + Debt 794.3m - CCE 78.0m)
Interest Coverage Ratio = 4.86 (Ebit TTM 165.4m / Interest Expense TTM 34.0m)
EV/FCF = 61.63x (Enterprise Value 3.32b / FCF TTM 53.9m)
FCF Yield = 1.62% (FCF TTM 53.9m / Enterprise Value 3.32b)
FCF Margin = 5.76% (FCF TTM 53.9m / Revenue TTM 935.3m)
Net Margin = 8.41% (Net Income TTM 78.7m / Revenue TTM 935.3m)
Gross Margin = 65.84% ((Revenue TTM 935.3m - Cost of Revenue TTM 319.5m) / Revenue TTM)
Gross Margin QoQ = 68.66% (prev 63.28%)
Tobins Q-Ratio = 0.96 (Enterprise Value 3.32b / Total Assets 3.46b)
Interest Expense / Debt = 4.28% (Interest Expense 34.0m / Debt 794.3m)
Taxrate = 28.55% (31.4m / 110.0m)
NOPAT = 118.2m (EBIT 165.4m * (1 - 28.55%))
Current Ratio = 3.16 (Total Current Assets 2.43b / Total Current Liabilities 770.8m)
Debt / Equity = 0.41 (Debt 794.3m / totalStockholderEquity, last quarter 1.93b)
Debt / EBITDA = 3.39 (Net Debt 716.3m / EBITDA 211.5m)
Debt / FCF = 13.29 (Net Debt 716.3m / FCF TTM 53.9m)
Total Stockholder Equity = 1.92b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.29% (Net Income 78.7m / Total Assets 3.46b)
RoE = 4.10% (Net Income TTM 78.7m / Total Stockholder Equity 1.92b)
RoCE = 6.39% (EBIT 165.4m / Capital Employed (Equity 1.92b + L.T.Debt 665.7m))
RoIC = 4.34% (NOPAT 118.2m / Invested Capital 2.72b)
WACC = 4.54% (E(2.61b)/V(3.40b) * Re(4.99%) + D(794.3m)/V(3.40b) * Rd(4.28%) * (1-Tc(0.29)))
Discount Rate = 4.99% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 39.74 | Cagr: 0.80%
[DCF] Terminal Value 77.97% ; FCFF base≈40.0m ; Y1≈45.9m ; Y5≈67.5m
[DCF] Fair Price = 5.67 (EV 1.02b - Net Debt 716.3m = Equity 299.7m / Shares 52.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.41 | # QB: 0
Revenue Correlation: -96.98 | Revenue CAGR: -13.48% | SUE: -0.02 | # QB: 0
EPS current Quarter (2025-12-31): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS next Quarter (2026-06-30): EPS=1.62 | Chg30d=N/A | Revisions=+0% | Analysts=1
EPS current Year (2026-03-31): EPS=1.63 | Chg30d=-0.64% | Revisions=+6% | GrowthEPS=-34.4% | GrowthRev=-4.4%
EPS next Year (2027-03-31): EPS=1.76 | Chg30d=+4.86% | Revisions=+46% | GrowthEPS=+3.0% | GrowthRev=+4.5%
[Analyst] Revisions Ratio: +25% (up=16, down=9)